Septerna, Inc. Diluted Shares Outstanding (Weighted Average)
Septerna, Inc. (SEPN) reported Diluted Shares Outstanding (Weighted Average) of 45.04 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-10
- Septerna, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 45.04M shares, a 1.98% increase year-over-year.
- Septerna, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 44.76M shares, a 1.87% increase year-over-year.
- Septerna, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 44.58M shares, a 36.96% increase year-over-year.
- Septerna, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 45.60M shares, a 1766.13% increase year-over-year.
- Septerna, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 44.26M shares, a 347.46% increase from fiscal 2024.
- Septerna, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 9.89M shares, a 354.32% increase from fiscal 2023.
- Septerna, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 2.18M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 45.04M shares 10-Q · filed 2026-08-10 | 44.90M shares 10-Q · filed 2026-08-10 | 44.79M shares derived: average of 3 quarters · filed 2026-08-10 | 45.00M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 44.76M shares 10-Q · filed 2026-05-11 | 44.67M shares derived: average of 2 quarters · filed 2026-05-11 | 44.98M shares derived: average of 3 quarters · filed 2026-05-11 | 44.78M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | 44.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 45.09M shares derived: average of 2 quarters · filed 2026-03-09 | 44.78M shares derived: average of 3 quarters · filed 2026-08-10 | 44.26M shares 10-K · filed 2026-03-09 |
| 2025-09-30 | 45.60M shares 10-Q · filed 2025-11-10 | 44.88M shares derived: average of 2 quarters · filed 2026-08-10 | 44.15M shares 10-Q · filed 2025-11-10 | 41.56M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | 44.17M shares 10-Q · filed 2026-08-10 | 44.05M shares 10-Q · filed 2026-08-10 | 40.22M shares derived: average of 3 quarters · filed 2026-08-10 | 30.77M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | 43.94M shares 10-Q · filed 2026-05-11 | 38.24M shares derived: average of 2 quarters · filed 2026-05-11 | 26.31M shares derived: average of 3 quarters · filed 2026-05-11 | 20.32M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 32.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 17.50M shares derived: average of 2 quarters · filed 2026-03-09 | 12.44M shares derived: average of 3 quarters · filed 2026-03-09 | 9.89M shares 10-K · filed 2026-03-09 |
| 2024-09-30 | 2.44M shares 10-Q · filed 2025-11-10 | 2.39M shares derived: average of 2 quarters · filed 2025-11-10 | 2.34M shares 10-Q · filed 2025-11-10 | 2.53M shares derived: average of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | 2.34M shares 10-Q · filed 2025-08-11 | 2.28M shares 10-Q · filed 2025-08-11 | 2.56M shares derived: average of 3 quarters · filed 2025-08-11 | 2.42M shares derived: average of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | 2.23M shares 10-Q · filed 2025-05-15 | 2.68M shares derived: average of 2 quarters · filed 2025-05-15 | 2.45M shares derived: average of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | 3.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 2.57M shares derived: average of 2 quarters · filed 2025-03-27 | 2.18M shares 10-K · filed 2025-03-27 | |
| 2023-09-30 | 2.01M shares 10-Q · filed 2024-11-20 | 1.86M shares 10-Q · filed 2024-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |